BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11139203)

  • 1. Anti-Trypanosoma cruzi immunoglobulin G1 can be a useful tool for diagnosis and prognosis of human Chagas' disease.
    Cordeiro FD; Martins-Filho OA; Da Costa Rocha MO; Adad SJ; Corrêa-Oliveira R; Romanha AJ
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):112-8. PubMed ID: 11139203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovations in diagnosis and post-therapeutic monitoring of Chagas disease: Simultaneous flow cytometric detection of IgG1 antibodies anti-live amastigote, anti-live trypomastigote, and anti-fixed epimastigote forms of Trypanosoma cruzi.
    Alessio GD; Côrtes DF; Machado de Assis GF; Júnior PA; Ferro EA; Antonelli LR; Teixeira-Carvalho A; Martins-Filho OA; de Lana M
    J Immunol Methods; 2014 Nov; 413():32-44. PubMed ID: 25064148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry, a new approach to detect anti-live trypomastigote antibodies and monitor the efficacy of specific treatment in human Chagas' disease.
    Martins-Filho OA; Pereira ME; Carvalho JF; Cançado JR; Brener Z
    Clin Diagn Lab Immunol; 1995 Sep; 2(5):569-73. PubMed ID: 8548536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High specificity of Trypanosoma cruzi epimastigote ribonucleoprotein as antigen in serodiagnosis of Chagas' disease.
    Solana ME; Katzin AM; Umezawa ES; Miatello CS
    J Clin Microbiol; 1995 Jun; 33(6):1456-60. PubMed ID: 7650167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas' disease.
    Morgan J; Dias JC; Gontijo ED; Bahia-Oliveira L; Correa-Oliveira R; Colley DG; Powell MR
    Am J Trop Med Hyg; 1996 Oct; 55(4):355-9. PubMed ID: 8916788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-conventional flow cytometry approaches to detect anti-Trypanosoma cruzi immunoglobulin G in the clinical laboratory.
    Vitelli-Avelar DM; Sathler-Avelar R; Wendling AP; Rocha RD; Teixeira-Carvalho A; Martins NE; Dias JC; Rassi A; Luquetti AO; Elói-Santos SM; Martins-Filho OA
    J Immunol Methods; 2007 Jan; 318(1-2):102-12. PubMed ID: 17161421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-house ELISA method to analyze anti-Trypanosoma cruzi IgG reactivity for differential diagnosis and evaluation of Chagas disease morbidity.
    Santos Lda S; Torres RM; Machado-de-Assis GF; Bahia MT; Martins HR; Teixeira-Carvalho A; Coelho-Dos-Reis JG; Albajar-Viñas P; Martins-Filho OA; Lana Md
    Rev Soc Bras Med Trop; 2012 Feb; 45(1):35-44. PubMed ID: 22370826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind study to evaluate flow cytometry analysis of anti-live trypomastigote antibodies for monitoring treatment efficacy in cases of human Chagas' disease.
    Martins-Filho OA; Eloi-Santos SM; Teixeira Carvalho A; Oliveira RC; Rassi A; Luquetti AO; Rassi GG; Brener Z
    Clin Diagn Lab Immunol; 2002 Sep; 9(5):1107-13. PubMed ID: 12204967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High resolution of Trypanosoma cruzi amastigote antigen in serodiagnosis of different clinical forms of Chagas' disease.
    Matsumoto TK; Hoshino-Shimizu S; Nakamura PM; Andrade HF; Umezawa ES
    J Clin Microbiol; 1993 Jun; 31(6):1486-92. PubMed ID: 8314991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chagas' disease: IgG isotypes against cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens of Trypanosoma cruzi in chronic Chagasic patients.
    Verçosa AF; Lorena VM; Carvalho CL; Melo MF; Cavalcanti MG; Silva ED; Ferreira AG; Pereira VR; Souza WV; Gomes YM
    J Clin Lab Anal; 2007; 21(5):271-6. PubMed ID: 17847109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to Trypanosoma cruzi express idiotypic patterns that can differentiate between patients with asymptomatic or severe Chagas' disease.
    Reis DD; Gazzinelli RT; Gazzinelli G; Colley DG
    J Immunol; 1993 Feb; 150(4):1611-8. PubMed ID: 8432996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG subclasses responsible for immune clearance in mice infected with Trypanosoma cruzi.
    Brodskyn CI; Silva AM; Takehara HA; Mota I
    Immunol Cell Biol; 1989 Dec; 67 ( Pt 6)():343-8. PubMed ID: 2516504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG subclass reactivity to Trypanosoma cruzi in chronic chagasic patients.
    Hernández-Becerril N; Nava A; Reyes PA; Monteón VM
    Arch Cardiol Mex; 2001; 71(3):199-205. PubMed ID: 11665655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troponin T autoantibodies correlate with chronic cardiomyopathy in human Chagas disease.
    Nunes DF; Guedes PM; Andrade Cde M; Câmara AC; Chiari E; Galvão LM
    Trop Med Int Health; 2013 Oct; 18(10):1180-92. PubMed ID: 23906320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients.
    Flechas ID; Cuellar A; Cucunubá ZM; Rosas F; Velasco V; Steindel M; Thomas Mdel C; López MC; González JM; Puerta CJ
    BMC Infect Dis; 2009 Nov; 9():186. PubMed ID: 19939275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanosoma cruzi: characterization of two recombinant antigens with potential application in the diagnosis of Chagas' disease.
    Gruber A; Zingales B
    Exp Parasitol; 1993 Feb; 76(1):1-12. PubMed ID: 8467895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by sera from Chagas' disease patients: prognosis value in Chagas disease.
    Laucella SA; de Titto EH; Segura EL
    Acta Trop; 1996 Dec; 62(3):151-62. PubMed ID: 9025983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of an immunodominant antigenic epitope from Trypanosoma cruzi as a biomarker of chronic Chagas' disease pathology.
    Thomas MC; Fernández-Villegas A; Carrilero B; Marañón C; Saura D; Noya O; Segovia M; Alarcón de Noya B; Alonso C; López MC
    Clin Vaccine Immunol; 2012 Feb; 19(2):167-73. PubMed ID: 22155766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies reactive to Trypanosoma cruzi epimastigotes or amastigotes express different idiotypic patterns if from patients with different clinical forms of Chagas' disease.
    Ribeiro-Rodrigues R; Colley DG; Correa-Oliveira R; Carter CE
    Scand J Immunol; 1996 Jun; 43(6):671-9. PubMed ID: 8658057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isotype of lytic antibodies in serum of Chagas' disease patients.
    Romeiro SA; Takehara HA; Mota I
    Clin Exp Immunol; 1984 Feb; 55(2):413-8. PubMed ID: 6421519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.